Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,068 public trials 1,853 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Completed

Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer

NCT06091943

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
View all 15 locations
View Trial Details
Completed

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

NCT04354246

Conditions
Adnexal Diseases, Advanced Cancer, Blood Protein Disorders, +53 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • START Midwest. Grand Rapids, Michigan, United States
  • The Ohio State University Comprehensive Cancer Center. Columbus, Ohio, United States
View Trial Details
Completed

A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

NCT06131398

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +29 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Alliance for Multispecialty Research - Kansas City Merriam, Kansas, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View all 25 locations
View Trial Details
Completed

A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors

NCT05858164

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • AdventHealth medical Group Oncology Research at Celebration Celebration, Florida, United States
  • Brigette Harris Cancer Pavilion at Henry Ford Cancer Center - Detroit Detroit, Michigan, United States
  • START | San Antonio San Antonio, Texas, United States
  • The Kinghorn Cancer Centre - Medical Oncology Department Darlinghurst, New South Wales, Australia
View all 16 locations
View Trial Details
Completed

Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)

NCT05153239

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Genesis Cancer and Blood Hot Springs, Arkansas, United States
  • Florida Cancer Specialists - South Fort Myers, Florida, United States
  • Florida Cancer Specialists - North St. Petersburg, Florida, United States
View all 210 locations
View Trial Details

Related conditions